Currently browsing category

News

Celon Pharma S.A.’s innovative research and development project among the projects on inflammatory diseases to receive co-financing from the National Centre for Research and Development

The project entitled “Selective JAK inhibitor in treatment of immune diseases” received co-financing in the amount of PLN 21,712,490.32 under the Smart Growth Operational Programme 2014-2020. The aim of the project is preclinical evaluation and clinical development (phase I and IIa trials conducted on patients) of an innovative drug candidate …

Celon Pharma S.A’s Warsaw Stock Exchange IPO

Celon Pharma S.A.’s IPO was held on the main market of the Warsaw Stock Exchange on 17 October 2016. The share price on the first day of trading increased by 17.58 percent. 15,000,000 of B series ordinary shares were introduced into the regulated market of the Warsaw Stock Exchange on …

Celon Pharma S.A. commences its IPO

On September 12 a press conference of the Celon Pharma S.A Company took place. During the meeting, representatives of the Management Board presented the business plans for the company related to its public offering of B series shares.

Celon Pharma S.A. is on its way to the stock exchange

29 August The Polish Financial Supervision Authority approved the Prospectus of the Company, which means that its first listing on the Warsaw Stock Exchange may take place this autumn.  Celon Pharma S.A. will be the first biopharmaceutical company which at the same time specialises in developing, manufacturing and marketing of …

Meeting of a scientific and business consortium under the NoteSzHD project

On 14 March this year another working meeting was held for the research project: “New treatment for psychotic disorders and Huntington’s disease with special focus on cognitive deficits” – NoteSzHD, with Celon Pharma S.A. as the leader. The meeting was participated in by representatives of the Nencki Institute of Experimental Biology of the …

Celon Pharma at the International CEBC Congress

On 18th June 2016, Celon Pharma S.A. took part in the 2nd Central European Biomedical Congress which was held in Cracow. The theme of this year’s CEBC edition was “From emerging biochemical strategies to personalised medicine”. Aleksandra Stańczak, PhD – leader of the Oncology Research Group in the Celon Pharma …